Dex Liquidating Co. Uncategorized Contracts & Agreements

40 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
CARDICA, INC. EMPLOYEE PROPRIETARY INFORMATION AND INVENTIONS AGREEMENT
Dex Liquidating Co.
CA
2016
CARDICA, INC. INDUCEMENT PLAN ADOPTED BY THE BOARD OF DIRECTORS: MAY 20, 2015 AMENDED BY THE BOARD OF DIRECTORS: OCTOBER 3, 2015
Dex Liquidating Co.
CA
2015
CARDICA, INC. EMPLOYEE PROPRIETARY INFORMATION AND INVENTIONS AGREEMENT
Dex Liquidating Co.
CA
2015
Cardica, Inc. Inducement Plan Adopted by the Board of Directors: May 20, 2015
Dex Liquidating Co.
CA
2015
FINANCIAL STATEMENTS
Dex Liquidating Co.
2011
FINANCIAL STATEMENTS
Dex Liquidating Co.
2011
Current assets
Dex Liquidating Co.
2010
AGREEMENT
Dex Liquidating Co.
CA
2010
Shares Subject to
Dex Liquidating Co.
2009
CARDICA, INC.
Dex Liquidating Co.
NY
2009
Cardica, Inc.
Dex Liquidating Co.
CA
2009
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Dex Liquidating Co.
2008
Current assets
Dex Liquidating Co.
2008
Current assets
Dex Liquidating Co.
2008
Current assets
Dex Liquidating Co.
2008
Current assets
Dex Liquidating Co.
2008
Exhibit No
Dex Liquidating Co.
2007
Exhibit No
Dex Liquidating Co.
DE
2007
Exhibit No
Dex Liquidating Co.
2007
Current assets
Dex Liquidating Co.
2007
Exhibit No
Dex Liquidating Co.
DE
2007
Exhibit No
Dex Liquidating Co.
2007
Exhibit No
Dex Liquidating Co.
NY
2007
Exhibit No
Dex Liquidating Co.
NY
2007
Current assets
Dex Liquidating Co.
2007
Exhibit No
Dex Liquidating Co.
2007
Exhibit No
Dex Liquidating Co.
2007
Exhibit No
Dex Liquidating Co.
2007
Current assets
Dex Liquidating Co.
2007
CARDICA, INC.
Dex Liquidating Co.
CA
2006
Cardica, Inc.
Dex Liquidating Co.
2006
Our products minimize trauma to both the graft and target vessel and can be used without interrupting blood flow in the coronary artery or clamping the aorta, which can lead to...
Dex Liquidating Co.
DE
2006
Our products minimize trauma to both the graft and target vessel and can be used without interrupting blood flow in the coronary artery or clamping the aorta, which can lead to...
Dex Liquidating Co.
CA
2006
Our products minimize trauma to both the graft and target vessel and can be used without interrupting blood flow in the coronary artery or clamping the aorta, which can lead to...
Dex Liquidating Co.
MO
2006
Our products minimize trauma to both the graft and target vessel and can be used without interrupting blood flow in the coronary artery or clamping the aorta, which can lead to...
Dex Liquidating Co.
DE
2006
Our products minimize trauma to both the graft and target vessel and can be used without interrupting blood flow in the coronary artery or clamping the aorta, which can lead to...
Dex Liquidating Co.
DE
2006
Our products minimize trauma to both the graft and target vessel and can be used without interrupting blood flow in the coronary artery or clamping the aorta, which can lead to...
Dex Liquidating Co.
CA
2005
Our products minimize trauma to both the graft and target vessel and can be used without interrupting blood flow in the coronary artery or clamping the aorta, which can lead to...
Dex Liquidating Co.
CA
2005
Our products minimize trauma to both the graft and target vessel and can be used without interrupting blood flow in the coronary artery or clamping the aorta, which can lead to...
Dex Liquidating Co.
DE
2005
Our products minimize trauma to both the graft and target vessel and can be used without interrupting blood flow in the coronary artery or clamping the aorta, which can lead to...
Dex Liquidating Co.
DE
2005